PIA
NVRO

Piedmont Investment Advisors’s NEVRO CORP. NVRO Stock Holding History

Piedmont Investment Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-505
Closed -$40K – 2363
2018
Q2 		$40K Buy
+505
New +$41.9K ﹤0.01% 1375

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Piedmont Investment Advisors's NVRO Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 505 shares — an estimated $40K sold.

Piedmont Investment Advisors first reported a position in NVRO in Q2 2018 and held it in 1 quarter. The position peaked at $40K in Q2 2018. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 505 NEVRO CORP. shares in Q3 2018, an estimated $40K.
  • Piedmont Investment Advisors first reported a position in NEVRO CORP. in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's NEVRO CORP. position peaked at $40K in Q2 2018.
  • 171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.